Evidence map›Paper›PMID 38661344›Full record

ArticlemSystems2024

Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder.

Joann Phan, Diana C Calvo, Divya Nair, Suneer Jain, Thibaut Montagne, Summer Dietsche, Kelsey Blanchard, Shirin Treadwell, James Adams, Rosa Krajmalnik-Brown

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Supplementation with abioRxiv : the preprint server for biology · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review of Elevated Para-Cresol in Autism and Possible Impact on Symptoms.International journal of molecular sciences · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Joann PhanSun Genomics, Inc., San Diego, California, USA.ORCID 0000-0001-5798-4416
Diana C CalvoDepartment of Civil Engineering, Construction Management, and Environmental Engineering, Northern Arizona University, Flagstaff, Arizona, USA.
Divya NairSun Genomics, Inc., San Diego, California, USA.
Suneer JainSun Genomics, Inc., San Diego, California, USA.
Thibaut MontagneSun Genomics, Inc., San Diego, California, USA.
Summer DietscheSun Genomics, Inc., San Diego, California, USA.
Kelsey BlanchardSun Genomics, Inc., San Diego, California, USA.
Shirin TreadwellSun Genomics, Inc., San Diego, California, USA.
James AdamsBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0001-8683-4062
Rosa Krajmalnik-BrownBiodesign Center for Health Through Microbiomes, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0001-6064-3524
Arizona State University · USNorthern Arizona University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of prebiotics and probiotics (synbiotics when combined) to improve symptoms associated with autism spectrum disorder (ASD) has shown considerable inter-study variation, likely due to the complex, heterogeneous nature of the disorder and its associated behavioral, developmental, and gastrointestinal symptoms. Here, we present a precision synbiotic supplementation study in 296 children and adults diagnosed with ASD versus 123 age-matched neurotypical controls. One hundred seventy ASD participants completed the study. Baseline and post-synbiotic assessment of ASD and gastrointestinal (GI) symptoms and deep metagenomic sequencing were performed. Within the ASD cohort, there were significant differences in microbes between subpopulations based on the social responsiveness scale (SRS2) survey ( IMPORTANCE: Autism spectrum disorder (ASD) is prevalent in 1 out of 36 children in the United States and contributes to health, financial, and psychological burdens. Attempts to identify a gut microbiome signature of ASD have produced varied results. The limited pre-clinical and clinical population sizes have hampered the success of these trials. To understand the microbiome associated with ASD, we employed whole metagenomic shotgun sequencing to classify microbial composition and genetic functional potential. Despite being one of the most extensive ASD post-synbiotic assessment studies, the results highlight the complexity of performing such a case-control supplementation study in this population and the potential for a future therapeutic approach in ASD.

Indexed as

Autism Spectrum DisorderGastrointestinal MicrobiomeSynbioticsAdolescentAdultChildChild, PreschoolFemaleHumansMalePilot ProjectsProbioticsYoung AdultASDgut microbiomemetagenomicsopen-labelprebioticsprecisionprobioticssupplementssynbiotics

Identifiers

PMID38661344
PMCPMC11097633
OpenAlexW4395465178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.